[{"Assets_0_FY_USD":4531100000.0,"CommonStockSharesConverted_0_FY_shares":133423628.0,"EarningsPerShareBasic_1_FY_USD":0.62,"EarningsPerShareBasic_4_FY_USD":0.64,"EarningsPerShareDiluted_1_FY_USD":0.61,"EarningsPerShareDiluted_4_FY_USD":0.63,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":374500000.0,"NetIncomeLossConverted_1_FY_USD":82700000.0,"NetIncomeLossConverted_4_FY_USD":83600000.0,"RevenuesConverted_3_FY_USD":164700000.0,"RevenuesConverted_1_FY_USD":685300000.0,"RevenuesConverted_4_FY_USD":2463400000.0,"StockholdersEquity_0_FY_USD":1086700000.0,"StockholdersEquityConverted_0_FY_USD":1086700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":133201216.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":131226110.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-K","period":"20180630","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20180828"}]